Save time and get answers to complex questions with AI chat
Complera manufacturer?Pramlintide approval date?Patent expiration eu dabrafenib?Bortezomib market france?Combivent inhaler hfc 152a patents?
In the FDA’s Orange Book rating code, the first letter indicates the drug product’s therapeutic equivalence category—specifically whether the product is considered therapeutically equivalent to a listed reference listed drug (RLD).
The common letter used in practice is: - A: The active ingredient in the applicant’s drug product is considered therapeutically equivalent to the RLD (i.e., the generic can be substituted for the brand under the FDA’s therapeutic equivalence framework).
Other letters correspond to products that are not rated as therapeutically equivalent in the same way as category A (for example, when the product is not rated as therapeutically equivalent or when additional data are needed). The specific letter-to-meaning mapping depends on the exact Orange Book code shown.
If you share the full Orange Book rating code (or the letter and the product it appears next to), I can translate the first letter in that specific context.
Other Questions About First :